Dataset

Nalidixic acid, 389-08-2.1d

Nalidixic acid, 389-08-2

InChI	InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17)
SMILES	CCN1C=C(C(=O)O)C(=O)C2=C1N=C(C)C=C2
InChI Key	MHWLWQUZZRMNGJ-UHFFFAOYSA-N
Molecular Formula	C12H12N2O3
Exact Mass	232.230 g/mol

Data and Resources

Field	Value
DOI	10.57992/nmrxiv.p12.s74.d433
License URL	https://creativecommons.org/licenses/by/4.0/legalcode
Source	https://nmrxiv.org/D433
Version
Author	Mohr J, Porwal D, Chatterjee I, Oestreich M.
Maintainer
Language	english
MetadataCreated	2024-04-22T16:47:21.031135
MetadataModified	2024-09-23T09:35:45.857252
MetadataPublished	2022-11-09 09:57:24

Field	Value
Measurement Technique	13C nuclear magnetic resonance spectroscopy
Measurement Variables	NMR solvent : CDCl3 acquisition nucleus : ['13C'] NMR spectrum by dimensionality : 1 NMR probe : 5 mm PABBO BB-1H/19F/D Z-GRD Z129133/0001 Temperature : 298.2487 K magnetic field strength : 16.441106362506158 Tesla number of scans : 64 scans nuclear magnetic resonance pulse sequence : zgpg30 Spectral Width : 304.239683000041 number of data points : 34 points relaxation time measurement : 2.2 seconds

Data-Source Molecule ID	Data-Source
20123603	NMRShiftDB
SCHEMBL21736	SureChEMBL
MCULE-6808033849	Mcule
529362	eMolecules
4421	PubChem
PD001597	ProbesDrugs
3B91HWA56M	FDA SRS
LSM-5590	LINCS
389-08-2	ACToR
PA164746384	PharmGKB
Nalidixic-acid(NegGram)	Selleck
14773844	PubChem: Thomson Pharma
HMDB0014917	Human Metabolome Database
CB1194283	ChemicalBook
114048	Brenda
2148	Brenda
DB00779	DrugBank
C05079	KEGG Ligand
CHEMBL5	ChEMBL
SAM002554914	NIH Clinical Collection
100147	ChEBI
NIX	PDBe
NALIDIXIC ACID	clinicaltrials
NALIDIXIC ACID	rxnorm
HY-B0398	MedChemExpress
NEGGRAM	clinicaltrials
NALIDIXATE SODIUM	clinicaltrials
NALIDX	CCDC
J2.039G	Nikkaji
NALIDIXATE	rxnorm
ZINC000000057421	ZINC
1875	DrugCentral
21691	BindingDB
DTXSID3020912	EPA CompTox Dashboard
The data in this table is sourced from UniChem at EBI.